mental health neurodiversity
Expose Pharma Lobbying vs Mental Health Neurodiversity Crisis
The surge in outpatient psychiatric prescriptions was driven more by coordinated pharma lobbying than by genuine patient demand. In 2020, federal mental health spending jumped 46% as lobbying dollars flooded Washington, setting the stage for a decade of policy twists and prescription spikes. Medical Disclaimer: This article is for informational